Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group
Modest, D.P., Ricard, I., Heinemann, V., Hegewisch-Becker, S., Schmiegel, W., Porschen, R., Stintzing, S., Graeven, U., Arnold, D., von Weikersthal, L.F., Giessen-Jung, C., Stahler, A., Schmoll, H.J., Jung, A., Kirchner, T., Tannapfel, A., Reinacher-Schick, A.
Published in Annals of oncology (01.09.2016)
Published in Annals of oncology (01.09.2016)
Get full text
Journal Article
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
Sommerhäuser, G, Kurreck, A, Stintzing, S, Heinemann, V, von Weikersthal, L Fischer, Dechow, T, Kaiser, F, Karthaus, M, Schwaner, I, Fuchs, M, König, A, Roderburg, C, Hoyer, I, Quante, M, Kiani, A, Fruehauf, S, Müller, L, Reinacher-Schick, A, Ettrich, T J, Stahler, A, Modest, D P
Published in BMC cancer (27.07.2022)
Published in BMC cancer (27.07.2022)
Get full text
Journal Article
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma - results of the Conko-007 multicenter trial
Wittel, U A, Lubgan, D, Ghadimi, M, Belyaev, O, Uhl, W, Bechstein, W O, Grützmann, R, Hohenberger, W M, Schmid, A, Jacobasch, L, Croner, R S, Reinacher-Schick, A, Hopt, U T, Pirkl, A, Oettle, H, Fietkau, R, Golcher, H
Published in BMC cancer (22.10.2019)
Published in BMC cancer (22.10.2019)
Get full text
Journal Article
Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial
Quidde, J., Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C.A., Killing, B., Depenbusch, R., Steffens, C.-C., Lange, T., Dietrich, G., Stoehlmacher, J., Reinacher, A., Tannapfel, A., Trarbach, T., Marschner, N., Schmoll, H.-J., Hinke, A., Al-Batran, S.-E., Arnold, D.
Published in Annals of oncology (01.12.2016)
Published in Annals of oncology (01.12.2016)
Get full text
Journal Article
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group
Seufferlein, T., Uhl, W., Kornmann, M., Algül, H., Friess, H., König, A., Ghadimi, M., Gallmeier, E., Bartsch, D.K., Lutz, M.P., Metzger, R., Wille, K., Gerdes, B., Schimanski, C.C., Graupe, F., Kunzmann, V., Klein, I., Geissler, M., Staib, L., Waldschmidt, D., Bruns, C., Wittel, U., Fichtner-Feigl, S., Daum, S., Hinke, A., Blome, L., Tannapfel, A., Kleger, A., Berger, A.W., Kestler, A.M.R., Schuhbaur, J.S., Perkhofer, L., Tempero, M., Reinacher-Schick, A.C., Ettrich, T.J.
Published in Annals of oncology (01.01.2023)
Published in Annals of oncology (01.01.2023)
Get full text
Journal Article
Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
Harder, J, Ihorst, G, Heinemann, V, Hofheinz, R, Moehler, M, Buechler, P, Kloeppel, G, Röcken, C, Bitzer, M, Boeck, S, Endlicher, E, Reinacher-Schick, A, Schmoor, C, Geissler, M
Published in British journal of cancer (13.03.2012)
Published in British journal of cancer (13.03.2012)
Get full text
Journal Article
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the ‘burden of therapy’ method
Haas, M., Waldschmidt, D.T., Stahl, M., Reinacher-Schick, A., Freiberg-Richter, J., Fischer von Weikersthal, L., Kaiser, F., Kanzler, S., Frickhofen, N., Seufferlein, T., Dechow, T., Mahlberg, R., Malfertheiner, P., Illerhaus, G., Kubicka, S., Abdul-Ahad, A., Snijder, R., Kruger, S., Westphalen, C.B., Held, S., von Bergwelt-Baildon, M., Boeck, S., Heinemann, V.
Published in European journal of cancer (1990) (01.03.2021)
Published in European journal of cancer (1990) (01.03.2021)
Get full text
Journal Article
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy
Goede, V, Coutelle, O, Neuneier, J, Reinacher-Schick, A, Schnell, R, Koslowsky, T C, Weihrauch, M R, Cremer, B, Kashkar, H, Odenthal, M, Augustin, H G, Schmiegel, W, Hallek, M, Hacker, U T
Published in British journal of cancer (26.10.2010)
Published in British journal of cancer (26.10.2010)
Get full text
Journal Article
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial
Fietkau, R., Grützmann, R., Wittel, U. A., Croner, R. S., Jacobasch, L., Neumann, U. P., Reinacher-Schick, A., Imhoff, D., Boeck, S., Keilholz, L., Oettle, H., Hohenberger, W. M., Golcher, H., Bechstein, W. O., Uhl, W., Pirkl, A., Adler, W., Semrau, S., Rutzner, S., Ghadimi, M., Lubgan, D.
Published in Strahlentherapie und Onkologie (01.01.2021)
Published in Strahlentherapie und Onkologie (01.01.2021)
Get full text
Journal Article
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group
Schmiegel, W., Reinacher-Schick, A., Arnold, D., Kubicka, S., Freier, W., Dietrich, G., Geißler, M., Hegewisch-Becker, S., Tannapfel, A., Pohl, M., Hinke, A., Schmoll, H.J., Graeven, U.
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the ‘Arbeitsgemeinschaft Internistische Onkologie’
Haas, M., Siveke, J.T., Schenk, M., Lerch, M.M., Caca, K., Freiberg-Richter, J., Fischer von Weikersthal, L., Kullmann, F., Reinacher-Schick, A., Fuchs, M., Kanzler, S., Kunzmann, V., Ettrich, T.J., Kruger, S., Westphalen, C.B., Held, S., Heinemann, V., Boeck, S.
Published in European journal of cancer (1990) (01.05.2018)
Published in European journal of cancer (1990) (01.05.2018)
Get full text
Journal Article
Final results of the randomized phase II VOLFI trial (AIO- KRK0109): mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild-type metastatic colorectal cancer (mCRC)
Geissler, M., Tannapfel, A., Reinacher-Schick, A., Martens, U., Ricke, J., Riera-Knorrenschield, J., Kanzler, S., Held, S., Heinemann, V., Seufferlein, T., Modest, D.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
1st-line mFOLFOXIRI + panitumumab vs FOLFOXIRI treatment of RAS wt mCRC: A randomized phase II VOLFI trial of the AIO (KRK-0109)
Geissler, M, Klingler, T, Riera Knorrenschild, J, Tannapfel, A, Greeve, J, Seufferlein, T, Kanzler, S, Held, S, Heinemann, V, Reinacher-Schick, A, Martens, U M
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial
Golan, T., Hammel, P., Reni, M., Van Cutsem, E., Macarulla, T., Hall, M., Park, J., Hochhauser, D., Arnold, D., Oh, D., Reinacher-Schick, A., Tortora, G., Algül, H., O’Reilly, E., McGuinness, D., Cui, K., Schlienger, K., Locker, G., Kindler, H.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
A composite liquid biomarker for non-invasive diagnosis of resectable pancreatic ductal adenocarcinoma
Berger, A.W., Ettrich, T.J., Schwerdel, D., Reinacher-Schick, A., Algül, H., König, A.-O., Gallmeier, E., Wille, K., Daum, S., Geissler, M., Tannapfel, A., Uhl, W., Seufferlein, T.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
Kurreck, A., Geissler, M., Martens, U. M., Riera-Knorrenschild, J., Greeve, J., Florschütz, A., Wessendorf, S., Ettrich, T., Kanzler, S., Nörenberg, D., Seidensticker, M., Held, S., Buechner-Steudel, P., Atzpodien, J., Heinemann, V., Stintzing, S., Seufferlein, T., Tannapfel, A., Reinacher-Schick, A. C., Modest, D. P.
Published in Journal of cancer research and clinical oncology (01.10.2020)
Published in Journal of cancer research and clinical oncology (01.10.2020)
Get full text
Journal Article
Geriatric assessment and the variance of treatment recommendations in geriatric patients with gastrointestinal cancer—a study in AIO oncologists
Büttelmann, M., Hofheinz, R.D., Kröcher, A., Ubbelohde, U., Stintzing, S., Reinacher-Schick, A., Bornhäuser, M., Folprecht, G.
Published in ESMO open (01.02.2023)
Published in ESMO open (01.02.2023)
Get full text
Journal Article
mFOLFOXIRI + Panitumumab versus FOLFOXIRI as first-line treatment in patients with RAS wild- type metastatic colorectal cancer m(CRC): a randomized phase II VOLFI trial of the AIO (AIO- KRK0109)
Geissler, M., Klingler, T., Riera-Knorrenschield, J., Tannapfel, A., Seufferlein, T., Held, S., Florschütz, A., Kanzler, S., Heinemann, V., Reinacher-Schick, A., Martens, U.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article